Literature DB >> 27621799

Vision Loss in Guillain-Barre Syndrome: Is it a Complication of Guillain-Barre Syndrome or Just a Coincidence?

Sri Ramakrishnan1, Balakrishnan Kannan1, Aarathy Kannan2, E Prasanna Venkatesan3.   

Abstract

Entities:  

Year:  2016        PMID： 27621799      PMCID： PMC5000544          DOI： 10.4103/2008-322X.188405

Source DB:  PubMed          Journal:  J Ophthalmic Vis Res        ISSN： 2008-322X


× No keyword cloud information.
  5 in total

1.  Papilledema in the Guillain-Barré syndrome.

Authors:  S FELDMAN; J LANDAU; L HALPERN
Journal:  AMA Arch Neurol Psychiatry       Date:  1955-06

2.  Optic neuritis in a patient with Miller-Fisher syndrome.

Authors:  Praween Lolekha; Kammant Phanthumchinda
Journal:  J Med Assoc Thai       Date:  2008-12

3.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

4.  Visual evoked potentials in guillain-barré syndrome.

Authors:  Levent Güngör; Inci Güngör; Hilal Eser Oztürk; Musa Kazım Onar
Journal:  J Clin Neurol       Date:  2011-03-31       Impact factor: 3.077

5.  Guillain-Barre syndrome with posterior reversible encephalopathy syndrome.

Authors:  Basavaraj F Banakar; Guruprasad S Pujar; Amita Bhargava; Shubhkaran Khichar
Journal:  J Neurosci Rural Pract       Date:  2014-01
  5 in total
  2 in total

1.  Vision Loss in Guillain-Barre Syndrome; a Complication or a Coincidence.

Authors:  Mahmood Dhahir Al-Mendalawi
Journal:  J Ophthalmic Vis Res       Date:  2017 Jan-Mar

2.  Zika virus-induced neuro-ocular pathology in immunocompetent mice correlates with anti-ganglioside autoantibodies.

Authors:  Jacob T Beaver; Lisa K Mills; Dominika Swieboda; Nadia Lelutiu; Edward S Esser; Olivia Q Antao; Eugenia Scountzou; Dahnide T Williams; Nikolaos Papaioannou; Elizabeth Q Littauer; Ioanna Skountzou
Journal:  Hum Vaccin Immunother       Date:  2020-08-06       Impact factor: 4.526
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.